Introduction
The main activity of the Corporation is to invest in member pharmaceutical companies, including the leading pharmaceutical companies in the country. Many enterprises are members of the Corporation have strong financial capacity, extensive distribution network and GMP produced factory with modern technology. The corporation is currently one of only three units authorized by the Ministry of Health to conduct bioequivalence studies. bioequivalence research capacity of the Corporation is about 20 studies per year.
Business sector
History
Date of incorporation | 01/04/1971 |
Certificate of registration number | 0100109385 |
Date of issue | 04/07/2023 |
Capital | 2,370,000,000,000 |
Tax Code | 0100109385 |
Sectors & Industries | Health Care > Pharmaceuticals |
Listing information
Date of listing | 04/07/2023 |
Stock exchange | UPCOM |
Par Value | 10,000 |
Initial Listing Price | 10,400 |
Listing Volume | 237,000,000 |
Total Listing Value | 2,370,000,000,000 |
Management team
Đinh Xuân Hấn | Chairman of the Board of Directors |
Trần Đức Hùng | Vice-chairman of the Board |
Phạm Thị Xuân Hương | Members of the Board |
Nguyễn Hồng Nhung | Members of the Board |
Hàn Thị Khánh Vinh | Members of the Board |
Trần Văn Hải | Members of the Board |
Nguyễn Văn Khái | Board of internal controllers |
Hoàng Diệu Linh | Member of the Board of Internal controllers |
Ngô Thị Bích Thảo | Member of the Board of Internal controllers |
Kiều Thị Minh Hồng | Member of the Board of Internal controllers |
Hàn Thị Khánh Vinh | Chief of Executive Officer |
Lữ Thị Khánh Trân | Chief Accountant |
Đinh Xuân Hấn | Representative Spokesman |